Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 8/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 6/20 | 0.32 |
| ▸ | PDE4C | Q08493 | 6/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 6/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ACACB | O00763 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8268621 | 1.00 | PDE4A (0.32) | PDE4APDE4BPDE4CPDE4DRXRA | |
| SCHEMBL8267221 | 0.94 | PDE4A (0.34) | PDE4APDE4BPDE4CPDE4DPOLB | |
| SCHEMBL4465524 | 0.89 | PDE4B (0.42) | PDE4APDE4BPDE4CPDE4DPOLB | |
| SCHEMBL4462115 | 0.89 | PDE4B (0.42) | PDE4APDE4BPDE4CPDE4DPOLB | |
| SCHEMBL4475600 | 0.88 | PDE4B (0.41) | PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4464163 | 0.88 | PDE4B (0.41) | PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4460068 | 0.88 | PDE4B (0.41) | PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL8268619 | 0.84 | NPC1 (0.40) | POLBSMN1; SMN2 | |
| SCHEMBL4476612 | 0.83 | PDE4A (0.44) | PDE4APDE4BPDE4CPDE4DPOLB | |
| SCHEMBL8267064 | 0.82 | PDE4A (0.33) | PDE4APDE4BPDE4CPDE4DRXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006044955-A1 | PHOSPHODIESTERASE 4 INHIBITORS | MEMORY PHARMACEUTICALS CORPORATION (US) | 2006-04-27 | — | — | WO | disclosed |